These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9215985)

  • 1. Neurofilamentous swellings and axonal atrophy are of unclear significance to diketone toxicity: commentary on forum position paper.
    Sickles DW
    Neurotoxicology; 1997; 18(1):33-6; discussion 37-40. PubMed ID: 9215985
    [No Abstract]   [Full Text] [Related]  

  • 2. Axonal swellings vs atrophy: what is the relevance to gamma-diketone peripheral neuropathy? Commentary on forum position paper.
    DeCaprio AP
    Neurotoxicology; 1997; 18(1):25-7; discussion 37-40. PubMed ID: 9215982
    [No Abstract]   [Full Text] [Related]  

  • 3. The relevance of axonal swellings and atrophy to gamma-diketone neurotoxicity: a forum position paper.
    LoPachin RM; Lehning EJ
    Neurotoxicology; 1997; 18(1):7-22. PubMed ID: 9215980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of neurofilament swellings and axonal atrophy: commentary on forum position paper.
    Anthony DC
    Neurotoxicology; 1997; 18(1):23-4; discussion 37-40. PubMed ID: 9215981
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanistic importance of axonal atrophy and swelling in gamma-diketone axonopathy: commentary on forum position paper.
    Sayre LM; Gambetti P
    Neurotoxicology; 1997; 18(1):31-2; discussion 37-40. PubMed ID: 9215984
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein crosslinking correlates with axonal atrophy, swelling and degeneration in gamma-diketone neuropathy: commentary on forum position paper.
    Graham DG
    Neurotoxicology; 1997; 18(1):29-30; discussion 37-40. PubMed ID: 9215983
    [No Abstract]   [Full Text] [Related]  

  • 7. gamma-Diketone neuropathy: axon atrophy and the role of cytoskeletal protein adduction.
    LoPachin RM; DeCaprio AP
    Toxicol Appl Pharmacol; 2004 Aug; 199(1):20-34. PubMed ID: 15289087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport.
    Monaco S; Wongmongkolrit T; Shearson CM; Patton A; Schaetzle B; Autilio-Gambetti L; Gambetti P; Sayre LM
    Brain Res; 1990 Jun; 519(1-2):73-81. PubMed ID: 2118823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic neurofilamentous axonopathies -- accumulation of neurofilaments and axonal degeneration.
    Llorens J
    J Intern Med; 2013 May; 273(5):478-89. PubMed ID: 23331301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated diabetic neuropathy in axons without neurofilaments.
    Zochodne DW; Sun HS; Cheng C; Eyer J
    Brain; 2004 Oct; 127(Pt 10):2193-200. PubMed ID: 15289271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. dl- versus meso-3,4-dimethyl-2,5-hexanedione: a morphometric study of the proximo-distal distribution of axonal swellings in the anterior root of the rat.
    Rosenberg CK; Genter MB; Szakál-Quin G; Anthony DC; Graham DG
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):363-73. PubMed ID: 3824390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicants and the cytoskeleton.
    Graham DG
    Curr Opin Neurol; 1999 Dec; 12(6):733-7. PubMed ID: 10676757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distal axonopathy does not occur without neurofilament accumulation in gamma-diketone neuropathy: comparative studies of normal and neurofilament-deficient quail.
    Hirai T; Mizutani M; Ochiai K; Umemura T; Itakura C
    Acta Neuropathol; 1999 Jun; 97(6):552-6. PubMed ID: 10378373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of diketone neurotoxicity.
    DeCaprio AP
    Chem Biol Interact; 1985; 54(3):257-70. PubMed ID: 3902259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid and protein targets of 1,2-diacetylbenzene, a potent aromatic gamma-diketone that induces proximal neurofilamentous axonopathy.
    Kim MS; Hashemi SB; Spencer PS; Sabri MI
    Toxicol Appl Pharmacol; 2002 Aug; 183(1):55-65. PubMed ID: 12217642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice.
    Meier J; Couillard-Després S; Jacomy H; Gravel C; Julien JP
    J Neuropathol Exp Neurol; 1999 Oct; 58(10):1099-110. PubMed ID: 10515233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axon outgrowth and neurofilament protein expression in mouse neuroblastoma cells exposed to the neurotoxin MPTP.
    De Girolamo LA; Hargreaves AJ; Billett EE
    Biochem Soc Trans; 1997 Nov; 25(4):S575. PubMed ID: 9450003
    [No Abstract]   [Full Text] [Related]  

  • 18. Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease.
    Nobbio L; Gherardi G; Vigo T; Passalacqua M; Melloni E; Abbruzzese M; Mancardi G; Nave KA; Schenone A
    Eur J Neurosci; 2006 Mar; 23(6):1445-52. PubMed ID: 16553608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofilament functions in health and disease.
    Julien JP
    Curr Opin Neurobiol; 1999 Oct; 9(5):554-60. PubMed ID: 10508735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-mediated excitotoxic axonal damage is attenuated in the absence of myelin proteolipid protein.
    Fowler JH; Edgar JM; Pringle A; McLaughlin M; McCulloch J; Griffiths IR; Garbern JY; Nave KA; Dewar D
    J Neurosci Res; 2006 Jul; 84(1):68-77. PubMed ID: 16625661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.